DANIELLE CINCINELLI: Open Payments
NPI 1306091152 · ROSLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,960 in 82 payments from 14 companies in 2025. Trend: 2023 $1,756 · 2024 $1,295 · 2025 $1,960
Food & beverage: $1,765Education: $195
| Company | Payments | Amount |
|---|---|---|
| Actelion Pharmaceuticals US, Inc. | 12 | $367 |
| Alnylam Pharmaceuticals Inc. | 11 | $275 |
| AstraZeneca Pharmaceuticals LP | 11 | $220 |
| PFIZER INC. | 8 | $188 |
| SCPHARMACEUTICALS INC. | 9 | $180 |
| Abbott Laboratories | 7 | $176 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $146 |
| United Therapeutics Corporation | 5 | $102 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $71 |
| E.R. Squibb & Sons, L.L.C. | 2 | $59 |
Products named: AMVUTTRA, OPSUMIT, VYNDAQEL, FUROSCIX, UPTRAVI, FARXIGA, JARDIANCE, CARDIOMEMS.
Industry payments across NY — which companies pay providers there.
